Symbol | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
CAH | CEO, Pharmaceutical Segment | Nov 15, 2021 | Option Exercise | $51.44 | 4,391 | 225,873 | 81,965 | Nov 16, 2021, 04:25 PM |
CAH | CEO, Pharmaceutical Segment | Aug 15, 2021 | Option Exercise | $51.70 | 19,991 | 1,033,535 | 86,356 | Aug 17, 2021, 04:18 PM |
CAH | CEO, Pharmaceutical Segment | Nov 15, 2020 | Option Exercise | $57.43 | 4,362 | 250,510 | 61,124 | Nov 17, 2020, 07:19 AM |
CAH | CEO, Pharmaceutical Segment | Aug 15, 2020 | Option Exercise | $53.68 | 3,080 | 165,334 | 65,486 | Aug 17, 2020, 04:17 PM |
CAH | CEO, Pharmaceutical Segment | Nov 15, 2019 | Option Exercise | $54.75 | 4,144 | 226,884 | 48,074 | Nov 18, 2019, 04:53 PM |
Symbol | Relationship | Date | Transaction | Value($) |
CAH | CEO, Pharmaceutical Segment | Nov 15, 2021 | Option Exercise | 225,873 |
CAH | CEO, Pharmaceutical Segment | Aug 15, 2021 | Option Exercise | 1,033,535 |
CAH | CEO, Pharmaceutical Segment | Nov 15, 2020 | Option Exercise | 250,510 |
CAH | CEO, Pharmaceutical Segment | Aug 15, 2020 | Option Exercise | 165,334 |
CAH | CEO, Pharmaceutical Segment | Nov 15, 2019 | Option Exercise | 226,884 |